Skip to content

MOTS-c

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c, CAS 1628322-46-2) is a 16-amino acid mitochondrial-derived peptide with a molecular weight of 2,174.6 Da. Encoded within the mitochondrial 12S rRNA gene, MOTS-c represents a recently discovered class of bioactive mitochondrial peptides (MDPs) that translocate to the nucleus and cytoplasm to regulate metabolic gene expression. This peptide has emerged as a key research tool for understanding mitochondrial-nuclear communication and metabolic stress adaptation.

Technical Specifications

Property Value
CAS Number 1628322-46-2
Molecular Formula C₁₀₁H₁₅₉N₂₈O₂₃S₂
Molecular Weight 2,174.6 Da
Purity ≥98% (HPLC-verified)
Appearance Lyophilized white powder
Solubility Soluble in aqueous buffers and sterile water
Storage -20°C (lyophilized), 2–8°C (reconstituted)

Mechanism of Action

MOTS-c exerts metabolic regulatory effects by translocating to the nucleus under metabolic stress conditions (e.g., glucose deprivation, increased AMP/ATP ratio), where it directly interacts with transcription factors including NF-κB and STAT3 to modulate expression of genes involved in glycolysis, one-carbon metabolism, and the pentose phosphate pathway. Notably, MOTS-c promotes AMPK activation in skeletal muscle, enhancing glucose uptake and fatty acid oxidation while inhibiting de novo lipogenesis. In the folate-methionine cycle, MOTS-c increases AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) levels and endogenous AICAR production, providing a secondary AMPK activation mechanism. This mitochondrial-derived peptide also suppresses the mTORC1 pathway under nutrient stress, facilitating metabolic reprogramming from anabolic to catabolic states. Its retrograde signaling — from mitochondria to nucleus — represents a fundamental mechanism by which mitochondria directly regulate cellular metabolic adaptation.

Research Applications

  • Primary: Mitochondrial-nuclear retrograde signaling, cellular metabolic adaptation to stress
  • Secondary: Insulin sensitivity research, age-related metabolic decline, exercise mimetic pharmacology
  • Model Systems: In vitro (C2C12 myotubes, primary hepatocytes, HEK293 cells), in vivo mouse models (high-fat diet-induced insulin resistance, aging studies)

Quality Control & Analytical Methods

  • HPLC: ≥98% purity verification at 214/220 nm (C18 reversed-phase column)
  • Mass Spectrometry: ESI-MS for molecular weight confirmation (2,174.6 ±1.0 Da)
  • Peptide Content: Amino acid analysis (AAA) for net peptide content determination
  • Endotoxin: <1 EU/mg (LAL assay)
  • TFA Content: <1% (ion chromatography)

Stability & Storage

Condition Stability
-20°C (lyophilized) 24 months
4°C (lyophilized) 6 months
25°C (lyophilized) 1 month
Reconstituted (4°C) 7 days
Reconstituted (-20°C) 30 days

Key Research References

  • Lee et al. (2015) — The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. PMID: 25683715
  • Kim et al. (2018) — MOTS-c mediates exercise-induced benefits in age-related physical decline. Nat Commun. PMID: 29795255
  • Reynolds et al. (2021) — MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and metabolism. Aging Cell. PMID: 33448466

Source & Purchase

For researchers requiring research-grade MOTS C with full analytical documentation including HPLC, LC-MS, and Certificate of Analysis, visit the HK Peptides product page for specifications, bulk pricing, and ordering.

View MOTS C Product →

FAQ

Q: What purity level is standard for MOTS-c? A: HK Peptides supplies MOTS-c at ≥98% purity by HPLC with full COA documentation.

Q: How should MOTS-c be stored for research use? A: Lyophilized MOTS-c should be stored at -20°C. Reconstituted solutions at 4°C for short-term use (up to 7 days).